[HTML][HTML] A quarter century of APOE and Alzheimer's disease: progress to date and the path forward
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
[引用][C] A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - cir.nii.ac.jp
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
[HTML][HTML] A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - Elsevier
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - NEURON, 2019 - pubblicazioni.unicam.it
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - europepmc.org
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - profiles.wustl.edu
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi “monogenic” role of apolipoprotein E …
[PDF][PDF] A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - pubblicazioni.unicam.it
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi ''monogenic''role of apolipoprotein E …
by lingering uncertainty over how to treat the quasi ''monogenic''role of apolipoprotein E …